Submit your resume today!
Popular Blog Alert! BioAgilytix's Todd Lester answers questions about using a one-assay approach to develop & validate ADA #assays supporting #biosimilar programs. http://bit.ly/30MbU78
Researchers have identified 5 #immuneresponse markers that, collectively, were able to distinguish between those #COVID19 patients who convalesced from the infection, and those who didn't survive the disease. Read more: http://bit.ly/2XPdNOC via @GENbio
In a huge step towards improving ED&I in the #LifeSciences, @bmsnews announced that it will commit $300 million over the next 5 years to tackle racial health disparities & accelerate its D&I efforts. Learn more: https://bit.ly/33TT2Fo
#DidYouKnow? BioAgilytix's 90%+ employee retention rate leads our industry. Employees get to work with a dedicated team & customers are able to build partnerships with us for the long-term – a true win-win!
See how you can work with us: bit.ly/3kEHvjo & how we can work together: bit.ly/2CjEFin #BioAgilytixCareers #TheBioAgilytixDifference
What's driving gene therapy innovation forward? BioAgilytix's infographic looks at how past events are informing new breakthroughs in this exciting and revolutionary therapeutic field. Download it here >> bit.ly/3jqowbk
Have you explored all BioAgilytix Diagnostics has to offer when it comes to testing? View our test menu and areas of specialty – like infectious disease (including COVID-19!!) testing, diagnostic immunology, and more: bit.ly/2Duf4nv
Services
Platforms
